Management of Pigmentary Disorders
Management of Pigmentary Disorders
复制标题
色素性疾病的治疗
DOI：
10.1007/978-3-030-64830-5_10
复制
发表时间：
2021
期刊：
影响因子：
--
通讯作者：
V. Callender
中科院分区：
文献类型：
--
作者：
L. Payne;Kamaria N. Nelson;V. Callender
色素沉着疾病，包括色素沉着过度和色素沉着不足，是皮肤科中常见的疾病。它们可能是由多种潜在的全身性疾病和感染引起的，也可能是原发性皮肤疾病和继发于损伤或外伤的疾病。导致这两种类型的色素改变的影响因素包括对黑素细胞的影响以及黑色素产生的活性和速率。本章将讨论的最常见的色素沉着不足疾病包括炎症后色素沉着不足、色素沉着不足的蕈样肉芽肿、白糠疹、花斑癣、进行性黄斑黑色素沉着症、特发性点滴状黑色素沉着症和白癜风。讨论的色素沉着过度病症包括炎症后色素沉着过度、黄褐斑、色素性扁平苔藓、持久性变色性红斑以及引起色素沉着过度的药物诱导和代谢病症。
Disorders of pigmentation, both hyper- and hypopigmentation, are common entities encountered in dermatology. They can be caused by a variety of underlying systemic diseases and infections, as well as present as primary cutaneous disorders and secondary to injury or trauma. Contributing factors leading to both types of pigmentary alterations include both an effect on melanocytes and the activity and rate of melanin production. The most common disorders of hypopigmentation that will be discussed in this chapter include post-inflammatory hypopigmentation, hypopigmented mycosis fungoides, pityriasis alba, tinea versicolor, progressive macular hypomelanosis, idiopathic guttate hypomelanosis, and vitiligo. Hyperpigmentation disorders to be discussed include post-inflammatory hyperpigmentation, melasma, lichen planus pigmentosus, erythema dyschromicum perstans, and drug-induced and metabolic conditions causing hyperpigmentation.
DOI：
10.1034/j.1600-0749.2003.00032.x
发表时间：
2003-06-01
期刊：
PIGMENT CELL RESEARCH
影响因子：
--
作者：
Alkhateeb, A;Fain, PR;Spritz, RA
通讯作者：
Spritz, RA
影响因子：
7
作者：
Richmond JM;Frisoli ML;Harris JE
通讯作者：
Harris JE